ABOUT PRECISION FOR MEDICINE
Precision for Medicine is an industry-leading global precision medicine clinical research organization and a leader in complex clinical development. Our clients benefit from advanced technologies and new approaches that compress timelines, gain efficiencies, and increase the probability of approval. Under one global roof, Precision has integrated sophisticated biomarker capabilities and laboratory expertise, worldwide CRO services, data intelligence solutions, and more. With 6 specialty labs and 3,500+ professionals worldwide, we help clients accelerate life-changing treatments and propel medicine forward.
FEATURED PRODUCTS
-
![GettyImages-953449116 clinical trial oversight]( "Smarter Oversight, Earlier Action")
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
![GettyImages-158649166 biospecimen]( "Custom Biospecimens Collections")
With an in-house donor center and database of donors, along with an established network of hospitals and care centers, Precision can source virtually any disease type or sample type biospecimens needed for your project.
-
![GettyImages-2158862132-vials-robotic-arm-filling-liquid-handling-lab]( "IVD And CDx: Comprehensive Services From Research To Regulatory")
Navigating diagnostic development requires deep scientific expertise and adept regulatory support. Comprehensive solutions offer biospecimens, biomarker development, clinical trial support, and global regulatory services.
-
![GettyImages-1987430372-business-consulting-office-table-graphs-tablet]( "IVD Regulatory Consulting Services")
With effective IVD regulatory consulting from an expert team, sponsors can transform challenges into competitive advantages and bring high-quality diagnostics to market more efficiently.
-
![GettyImages-184312672 FSP]( "Strategic Scalability: Functional Service Provider Solutions")
What services are available to help you ensure continuous functional coverage, enhancing business continuity, operational efficiency, and risk mitigation?
-
![GettyImages-1311977468 site payments]( "Empowering Clinical Programs With Centers Of Excellence")
The right site network can help transform clinical trial execution by aligning top-tier investigators and centers of excellence with high-quality clinical studies, driving faster patient access.
-
![GettyImages-1180547358-computer-research]( "Life-Changing Therapies Without A Lifetime Of Development")
Learn about this integrated suite of services that spans global CRO capabilities, central laboratory services, and IVD & CDx regulatory development consulting.
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "High-Content Flow Cytometry")
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
-
![GettyImages-1174677845-blood work-blood tubes]( "Precision Kitting: Every Sample Matters, Every Detail Counts")
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
-
![GettyImages-926522504 microscope pathology]( "Overview Of Precision For Medicine's Pathology Services")
Explore an integrated approach to support biomarker-driven development programs that accelerates your development timelines, helping you achieve your research goals faster and more effectively.
-
![GettyImages-151617200-petri dish-bacteria-cells]( "Translational And Biomarker Sciences: Enabling Breakthroughs")
Learn about expert services specializing in precision medicine and biomarker-driven contract and clinical research that can assist you through translational solutions.
-
![Human Cell-GettyImages-1533148452]( "Multiparametric Flow Cytometry: Spectral And Conventional Services")
Explore flow cytometry services designed to meet the sophisticated needs of contemporary scientific research and therapeutic development.
WEBINARS AND VIDEOS
CONTACT INFORMATION
Precision for Medicine
2 Bethesda Metro Ctr Ste 850
Bethesda, MD 20814-5398
UNITED STATES
Contact: Nandita Handoo
FEATURED ARTICLES
-
![Businessman investor analyzing company financial]( "Investor Relations, Clinical Operations, And The Future Of Biotech Financing")
Discover how integrating clinical execution with investor strategy can strengthen your position in a tougher capital landscape and accelerate your path to market.
-
![GettyImages-1687786674 hard_shell pill]( "Dose Optimization: A Strategic Lever In Oncology Drug Development")
Targeted therapies, immunotherapies, antibody–drug conjugates, and other biologics demand a patient-centered strategy that recognizes that higher doses do not always translate to better outcomes.
-
![GettyImages-1449007950-tumor-cancer-t-cell]( "Reflect On 20 Years Of Cancer Research With MIRROR Biospecimens")
Explore how the Matched & Integrated Repository for Rediscovered Oncology Research (MIRROR) for biospecimens can help unlock new discoveries from the tumors that shaped modern precision oncology.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "Lost In Translation: Turning Multi-Omic Chaos Into Clinical Clarity")
-
![GettyImages-506999858-scientists-cell-culture-lab-development]( "The Immune System's Secret Language: Unlocking Cellular Communication")
The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.
-
![GettyImages-1425355912-laboratory-centrifuge-vial-samples]( "Prospecting Biospecimen Collections To Power Precision Medicine")
High-quality biospecimens are the foundation of precision medicine success. Learn the five crucial steps—from planning to compliance—for a prospective biospecimen collection that is scientifically robust and accelerates your research.
-
![GettyImages-1903424167-medical-meeting-clinical-setting-doctors]( "Phase I Clinical Trial Designs: Bayesian Logistic Regression Model (BLRM)")
The Bayesian Logistic Regression Model (BLRM) is redefining Phase I clinical trial design by bringing flexibility, precision, and patient-centered safety into early drug development.
-
![GettyImages-1182436133 scientist, lab, research, oncology]( "Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)")
The benefits are clear: CRM accelerates dose finding, reduces patient exposure to unsafe doses, and improves trial efficiency.
-
![GettyImages-1903424167-medical-meeting-clinical-setting-doctors]( "Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue")
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
-
![GettyImages-1751848523-meeting-evaluation-charts-table]( "Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM, And Modern Adaptive Strategies")
As precision medicine evolves, trial designs must increasingly accommodate personalized therapies, adaptive strategies, and AI-driven modeling.
-
![GettyImages-1648451466-scientist-cell-culture-laboratory-pipette-research]( "Conducting Autologous Cell Therapy Research With Zero Sample Loss")
Autologous cell therapy trials require precision at every stage—and this biomarker-specific solid tumor study exemplified the challenge.
-
![GettyImages-1018358582-regulations-compliance-paper-magnifying-glass]( "FDA Draft Guidance On Overall Survival in Oncology Trials")
Historically regarded as the gold standard efficacy endpoint, Overall Survival (OS) in oncology trials is now positioned not only as a measure of therapeutic benefit but also as a critical safety endpoint.
-
![GettyImages-1327073953 scientist, lab, experiment, biomarker]( "How AI & Biomarkers Are Reshaping The Next Frontier In Drug Development")
Learn more about the importance of biomarker-driven drug development and the integration of laboratory science, clinical expertise, and regulatory strategy to accelerate targeted therapy development.
-
![GettyImages-1316437398-planning-strategy-data]( "Phase 1 Clinical Trial Designs And Strategies")
With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.
-
![GettyImages-655022598 timeline]( "Rescue Studies")
Clinical trials frequently encounter delays, and rescue studies have become vital to address this challenge, especially in complex therapeutic areas.
-
![GettyImages-597971990 AAV virus]( "Understanding Immunogenicity In AAV Gene Therapy")
As adeno-associated virus-based gene therapies progress toward clinical use, effectively managing immunogenicity risk is critical to patient selection, therapeutic durability, and regulatory success.
-
![GettyImages-1434534146-neurologic-disease]( "Rarefied Thinking In Rare Disease Research")
This integrated approach to rare disease research combines clinical, operational, laboratory, regulatory, and data management expertise to maximize insights from every patient interaction.
-
![Cancer-in-blood-GettyImages-1303505360]( "Breaking Through In Hematologic Malignancies")
Explore the hematology-oncology landscape and a strategic preview of the challenges and opportunities that are redefining care for blood cancers today.
-
![GettyImages-1182436133 scientist, lab, research, oncology]( "Managing Cohorts In Early Phase Oncology Trials")
Early‐phase oncology trials demand meticulous cohort management to safeguard patient safety, optimize enrollment, and maintain data integrity.
-
![GettyImages-2183708450-doctor-with-patient-tablet-doctors-office]( "Designing \"Seamless Phase 1/2\" Oncology Trials")
Selecting a CRO with deep oncology expertise and seamless trial experience is vital to navigate these complexities and deliver transformative therapies to patients faster.
CASE STUDIES
-
![GettyImages-1388560078-chimeric-antigen-receptor-cell]( "Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays")
Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.
-
![GettyImages-1787595822-virus-viral-bacteria-cell]( "Rapid Startup Phase 1 Cardiomyopathy CRISPR Gene Therapy")
Hereditary transthyretin amyloidosis (ATTRv) is very rare, prompting a Phase 1 trial of in vivo CRISPR/Cas9 gene editing to reduce mutant protein and stop cardiomyopathy progression.
-
![Doctor checking patients skin-GettyImages-1094162454]( "Use Of Epiontis ID In A Phase 2 Psoriasis Trial")
Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.
